Ferredoxin pseudogene

Ferredoxin pseudogene (ENSG00000234872) refers to a DNA sequence in the human genome that resembles the protein-coding ferredoxin gene but is predicted to be nonfunctional due to accumulated mutations and loss of coding potential[1][3]. By definition, **pseudogenes** like this one do not produce functional ferredoxin protein, and their primary distinction from genes is a lack of protein-coding capacity attributable to truncations, frame shifts, or other disabling mutations[1][3]. Most pseudogenes do not participate directly in canonical biological processes such as signal transduction, metabolism, transport, or cell cycle regulation. Nonetheless, emerging evidence indicates that certain pseudogenes, especially those transcribed into RNA, may exert regulatory effects on their parent gene or on other genes, and some have been implicated in disease mechanisms, including cancer as prognostic markers, although this functionality is generally not assigned to the ferredoxin pseudogene[2][3][5]. As such, ferredoxin pseudogene is **not considered a druggable target, receptor, enzyme, or transporter** and has no known aliases beyond its generic annotation. This entry is **incorrect as a therapeutic target** for drug development, disease association, or biomarker use. The correct classification is as a nonfunctional genetic element with possible RNA-level regulatory roles but no established function specific to the ferredoxin pseudogene in human health or disease[1][2][3][5].

Other names

FDXP (unofficial)ferredoxin pseudogene